Palau Pharma, S.A.
Records under this name other than patents Palau Pharma, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,879,867 | Crystalline antifungal compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,431,580 | 4-aminopyrimidine derivatives as histamine H4 receptor antagonists Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,501,735 | N-containing heteroaryl derivatives as JAK3 kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,946,257 | N-Containing Heteroaryl Derivatives as JAK3 Kinase Inhibitors Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,901,146 | Aminoalkylpyrimidine Derivatives as Histamine H4 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,536,194 | Pyrazolopyridine derivates Term ended Term ended Feb 8, 2026 · From the USPTO record | Term ended | Term ended Feb 8, 2026 | From the USPTO record |
| US 8,258,296 | Crystalline antifungal compounds Formerly held Lapsed on the fee record Ended Sep 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2024 | From the USPTO record |
| US 6,653,475 | Method for preparing pyrimidone derivatives with antifungal activity Formerly held Term ended Term ended Sep 9, 2022 · From the USPTO record | Term ended | Term ended Sep 9, 2022 | From the USPTO record |
| US 8,476,456 | Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives Lapsed on the fee record Ended Jul 2, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2021 | From the USPTO record |
| US 8,309,105 | Triflusal-containing polymers for stent coating Lapsed on the fee record Ended Nov 13, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 13, 2020 | From the USPTO record |